This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Partnerships In Clinical Trials Nominates Christine Pierre For Clinical Trial Business Woman Of The Year

ROCKVILLE, Md., April 10, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is pleased to announce that President Christine Pierre has been nominated for the Clinical Trial Business Woman of the Year Award.  This prestigious award, granted by the Partnerships in Clinical Trials (PCT), recognizes a woman who has exemplified strong and innovative leadership and has set an example to other women in the clinical trials industry on a global scale.  It will be presented as part of the upcoming Partnerships in Clinical Trials conference, which will take place April 21 - 24 in Orlando, Florida.  The winner will be chosen by the PCT Advisory Board members, made up of executives across the clinical trial landscape including sponsors, contract research organizations (CROs), and industry consultant experts.  

"This is truly an honor, not only to be nominated by my esteemed colleagues, but also because this nomination indicates that sites are truly being recognized for their contribution to the research ecosystem.  I have always worked from a position of passion and not recognition, however, it is wonderful to have this work acknowledged because it gives validity to the sites, their voice and collective influence," says Ms. Pierre.

In October 2012, at the Site Solutions Summit, an annual gathering of clinical trial stakeholders, Ms. Pierre announced the formation of SCRS, a trade association dedicated to providing a voice and community to clinical research sites across the globe.  As an SCRS representative, she has been appointed to the Board of the Metrics Champion Consortium (MCC), a global non-profit organization that develops standardized performance metrics for the clinical trials industry.  She is also a member of the Steering Committee of the Clinical Trials Transformation Initiative (CTTI), and a member of the Board of Advisors for both the Center for Information and Study on Clinical Research Participation (CISCRP) and Hands Across the Americas.

Ms. Pierre is internationally known for her expertise in clinical research site management and patient recruitment and retention in the clinical trials industry.  In this capacity, she is a frequent guest speaker at industry conferences, having addressed audiences in the United States and around the globe.

About SCRSSCRS is a trade organization representing global clinical research sites. SCRS' mission is to unify and amplify the voice of the global clinical research site community.  SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives.  Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will benefit from membership.  Visit www.myscrs.org.

SOURCE Society for Clinical Research Sites

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,086.63 -26.91 -0.16%
S&P 500 1,987.01 +3.48 0.18%
NASDAQ 4,473.6970 +17.6810 0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs